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Background: Patients with mitral restenosis who have undergone prior PTMC or surgical
commissurotomy have increased. Predictors of outcome of repeat PTMC in either subgroup
of patients may be different.
Aims and objectives: Aim was to assess and compare the immediate results of PTMC in
patients who had undergone a prior PTMC or surgical commissurotomy.
Methods and results: This is a single center, prospective, open label study. Of 70 patients in
study, 44 (62.85%) patients had prior history of PTMC and 26 (37.15%) had prior surgical
commissurotomy (closed/open). Average time from the initial procedure was 8.88  5.36
years overall, 6.75  3.38 for patients with prior PTMC and 16.73  3.67 for patients with
prior surgical commissurotomy. Prior PTMC group had 75% female, patients with prior
surgical commissurotomy were older (44  7 vs 33.57  9.1 years, p ¼ 0.001), had higher
NYHA class (III/IV in100% vs 86.36%, p ¼ 0.006.), higher atrial fibrillation (73.1% vs 25%
p < 0.0001) and higher Wilkins’ score (>8 in 88.46% vs 68.18%, p ¼ 0.05). Successful PTMC
was lower (65.4% vs 84.1%) in patients with prior surgical commissurotomy, though sta-
tistically not significant (p ¼ 0.07). After PTMC, mitral valve area, PA systolic pressure, LAballoon mitral valvotomy; CMC, closed mitral commissurotomy; LA, left atrium; LAMP, left
VA, mitral valve area; MVR, mitral valve replacement; NSR, normal sinus rhythm; NYHA,
tral commissurotomy; RHD, rheumatic heart disease; PA, pulmonary artery; PASP, pulmo-
neous transvenous mitral commissurotomy; TIA, transient ischemic attack.
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i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 1 6 4e1 6 8 165mean pressure and trans-mitral gradient were similar. Post procedure complications were
not different in both the groups.
Conclusion: PTMC for mitral restenosis in patients with prior surgical valvotomy is as
effective as in patients with prior PTMC despite older age, higher NYHA class, higher
Wilkins score and atrial fibrillation and can be considered in all patients with restenosis
irrespective of the type of past procedures done.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Rheumatic heart disease (RHD) is a common cause of mitral
stenosis in developing countries.1 Treatment of severe mitral
stenosis surgically by closed mitral commissurotomy (CMC)
was first developed in 1940’s.2 With the development of car-
diopulmonary bypass in 1960’s, open surgical mitral com-
missurotomy (OMC) and replacement of mitral valve became
the surgical procedure of choice. Percutaneous approach
became the therapy of choice for suitable valves after intro-
duction of percutaneous balloon dilatation techniques as
described by Inoue in 19843 and Lock et al in 1985.4 Modifica-
tion of their techniques further, have led to improved results.
Mitral restenosis after PTMC or surgical valvotomy is now
commonly seen.5 After a prior CMC, distorted cardiac anat-
omy because of a prior ventriculotomy, amputated left atrial
appendage and surgical adhesions6e10 is a concern in
attempting PTMC. Few studies comparing results of PTMC
done for mitral restenosis in patients with prior PTMC and
prior surgical commissurotomy, showed varying results in
success.6e10 Our study aims to compare the results of PTMC
for mitral restenosis in patients with prior PTMC and prior
surgical commissurotomy and determine the predictors of
outcome.2. Material & method
The study is a prospective, open label, single center study.
Consecutive patients, who underwent PTMC in our hospital,
from March 2007 to November 2012 for symptomatic mitral
restenosis after a previous successful PTMC or surgical com-
missurotomy were included in the study. Mitral restenosis
was defined by a valve area<1$5 cm2 and a loss >50% of the
initial gain in valve area at the first mitral commissurotomy
and symptomatic patients were considered for PTMC. Patients
with mitral regurgitation grade >2/4, left atrial thrombus not
responding to oral anticoagulants, extensive valve calcifica-
tions, patients needing surgical intervention for other valve or
coronary artery bypass grafting or patients who had limited
life expectancy due to other reasons were excluded.
Demographic profile and clinical variables importantly
included were age, gender, New York Heart Association
(NYHA) functional class at presentation, presence of atrial
fibrillation and heart failure, history regarding penicillin pro-
phylaxis, type and details of previous commissurotomy.
Echocardiography was performed by an independent echo-
cardiographer on the day preceding the PTMC and post-PTMC
after 24e48 h. Valve area was assessed by planimetry, Doppler
pressure half-time and Gorlin’s equation. Echocardiographywas done on a SiemenseAccuson 300 JPxmachine with a p4-
2 probe. The reference measurement for valve area was by
planimetry. Investigational variables included the echocar-
diographic Wilkins score, pre and post-PTMC mitral valve
area, severity of mitral regurgitation, mean gradient across
valve, Pulmonary artery systolic pressure, left atrial size and
other relevant echocardiographic parameters.
Trans-esophageal echocardiography was performed in pa-
tients with a suboptimal trans-thoracic study, patients with
history of a previous embolic event and in patients with a
possible left atrial thrombus as suspected by trans-thoracic
study. Patients with left atrial thrombus were treated with
oral anticoagulant for at least two months, and PTMC was
performed only if resolution of the left atrial thrombus was
demonstrated by a repeat trans-esophageal echocardiography.
All patients underwent PTMC using the trans-septal ante-
grade technique, after written informed consent. Single
balloon Inoue technique was used in all patients. The
maximum size of balloon inflation was determined by the
equation: Maximum balloon diameter (mm) ¼ (patient’s
height (cm)/10) þ 10. Successful PTMCwas defined as increase
in mitral valve area to  to 1.5 cm2 and/or increase in area to
more than twice of the initial area, with a decrease in trans-
mitral gradient to half of the initial value and without >2þ
increase in the severity of mitral regurgitation. Suboptimal
PTMC was defined as any increment in mitral valve area less
than defined as success. Procedural failure was defined as
inability to cross/dilate the mitral valve. Procedure related
variables included mean left atrial pressure, mean mitral
valve gradient before and after PTMC. Prospectively collected
procedure related complications like death, mitral valve
replacement (MVR), pericardial tamponade, thromboembo-
lism, post-PTMC mitral regurgitation >2þ were analyzed.
Continuous variables were expressed as mean  standard
deviation (SD), and categorical variables as percentage. Stu-
dent t test and chi-square analysis were carried out for com-
parison of continuous and categorical variables, respectively
using SPSS. p Values<0.05 were considered statistically
significant.3. Results
Of a total of 70 patients included in the study, 44 (62.85%)
patients had prior history of PTMC and 26 (37.15%) patients
had a prior surgical commissurotomy (closed/open). Average
time from the initial procedure was 8.88  5.36 years overall
and was 6.75  3.38 years for patients with prior PTMC vs
16.73  3.67 years for patients with prior surgical commis-
surotomy (p < 0.001). Patients in the prior PTMC group were
Table 1 e Comparison of baseline characteristics of patients with prior BMV and prior surgical commissurotomy.
Category Prior BMV (n ¼ 44) Prior surgical
commissurotomy
(n ¼ 26)
Duration of RHD (years)(mean 13.57  6.76) 9.68  3.52 20.1  5.75 p < 0.001
Mean age (years) (37.44  9.77) 33.57  9.125 44  7.009 p ¼ 0.01
No of pts Percentage No %
Age<40 (n ¼ 44) 36 81.81 8 30.76 p < 0.001
Age 40 (n ¼ 26) 8 18.18 18 69.23
Males (n ¼ 23) 11 25 12 46.15 p ¼ NS
Females (n ¼ 47) 33 75 14 53.84
Wilkins score >8 (n ¼ 53) 30 68.18 23 88.46 p ¼ 0.05
Wilkins  8 (n ¼ 17) 14 31.81 3 11.53
Functional class- mean 2.88  0.38 3.15  0.36 p ¼ 0.006
2 6 13.63 0 0
3 37 84.1 22 84.61
4 1 2.3 4 15.38
Pts in AF (n ¼ 30) 11 25 19 73.1 p < 0.0001
NSR (n ¼ 40) 33 75 7 26.92
Prior embolism 3 6.81 7 26.92
Rheumatic prophylaxis-
Yes 35 79.54 13 50 p ¼ 0.01
No 9 20.45 13 50
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whereas patients in prior surgical valvotomy group (Table 1)
were older (mean 44  7.009 vs 33.57  9.12 years, p ¼ 0.01),
had longer duration of rheumatic heart disease (mean
20.1  5.75 vs 9.68  3.52 years, p < 0.001), had worse NYHA
functional class (p ¼ 0.006) and more prevalent atrial fibrilla-
tion (73.1% vs 25%, p < 0.0001). There was no additional sig-
nificant aortic or other valve organic involvement in any of the
patient.
Baseline mitral valve area and hemodynamics were
similar in both the groups (MVA 0.87  0.13 vs 0.83  0.12 in
patients with prior PTMC and surgical commissurotomy
respectively, p ¼NS). Successful PTMC could be performed in
all patients. The balloon diameters used were 24, 26 and
28 mm with inflation ranging from 22 to 27 mm according to
patient’s height, valvular characteristics, area achieved
during stepwise dilatation and regurgitation developed.
Procedural success rate, mean and percentage changes of
parameters like mitral valve area (MVA), pulmonary artery
systolic pressure (PASP), left atrial mean pressure (LAMP) and
trans-mitral gradient were similar in the two groups (Table 2,
Table 3).Table 2 e Comparison of results in patients with prior BMV vs
Prior BMV group
n %
Results e success (n ¼ 54) 37 84.1
Results esuboptimal (n ¼ 16) 7 15.9
Before After
MVA (cm2) 0.87  0.13 1.63  0.
PA systolic pressure (mmHg) 65.95  19.84 40.11  9
Mean LA pressure (mmHg) 23.25  6.55 13.25  5
Trans mitral gradient (mmHg) 16.95  6.24 3.18  3There were total 6 cases of mitral regurgitation > grade 2.
All were commissural. 3 of them had prior PTMC and 3 had
prior surgical commissurotomy. There was no case needing
emergency valve replacement. There was no mortality. One
TIA occurred which completely recovered within 24 h.
Though with significant difference in baseline character-
istics overall success of PTMC in both the groups was equal
and complications also did not differ in both the groups.4. Discussion
PTMC has been the treatment of choice in suitable valves in
patients having symptomatic mitral stenosis. Surgical mitral
valve replacement or OMV is reserved in patients having
calcific valves, more than mild mitral regurgitation, severe
infra-valvular pathology and patients having persistent LAA
clot. Patients who have had a prior PTMC or surgical com-
missurotomy may have different results to PTMC in patients
with mitral restenosis, due to possible different anatomy.
Our study was a prospective study comparing characteristics
and the results of PTMC in patients having mitral restenosisprior surgical commissurotomy.
Prior surgical commissurotomy
n %
17 65.4 p ¼ 0.07
9 34.6
Before After
19 0.83  0.12 1.58  0.20 p ¼ 0.24
.04 66.19  13.36 42.84  11.81 p ¼ 0.27
.19 24.26  7.6 14.57  4.9 p ¼ 0.29
17.30  6.21 3.80  2.6 p ¼ 0.43
Table 3 e Percentage changes in various parameters in
both group.
% Changes in Prior BMV
group
Prior surgical
valvotomy
p
MVA ([) 87.35 90.36 NS
PASP (Y) 39.18 35.27 NS
LAMP (Y) 43.01 39.94 NS
Transmitral gradient (Y) 81.23 78.03 NS
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CMC).
Restenosis is time dependent and found to be associated
with poor long term functional results after good immediate
results and adverse clinical events 5 years after PTMC.11e15
The incidence has been reported to range from 4 to 39%
within 6 years of follow up and progressive decrease of MVA
overtime has been well documented.16e23 Chen et al24 re-
ported a decrease in MVA of 0.2 cm2 at 5 years and Trevino
et al25 reported a decrease of 0.25 cm2 at 3 years. Rate of pro-
gression of both the groups is varying from 16 to 19% in 4e4.5
years in prior surgical commissurotomy patients and 24e39%
in 3e5 years in prior PTMC group.6,8,26,27 Patients with prior
PTMC presented 6.75  3.38 years whereas patients with prior
surgical commissurotomy presented after 16.73  3.6 years of
the initial procedure in our study and which is similar to Iung
et al6 (6  2 years for post-PTMC patients) and slightly higher
than Ha et al9 (11.2 years after prior surgical commissur-
otomy). The age of patient with prior surgical commissur-
otomy was 57  13 years in study of Jang et al8 while in our
study it was 44  7.0 which was comparable to Ha et al9
(42.8  10.4 years). Our study had more patients with atrial
fibrillation and higher Wilkins score in prior surgical com-
missurotomy group as compared to other studies (73.1% in AF
in our study compared to 44% in Jang et al and 18% in Ha et al,9
Wilkins score >8 in 88.46% in our study compared to 50% in
Jang et al Mean Wilkins score being 9.42  0.96 in our study
compared to 6.6  3.3 in Ha et al9). The mean age of patients
with prior PTMC was 33.57  9.125 years in our study which
was similar to Iung et al6 (39  11 years) but different from
Pathan et al26 (58  13 years). Majority of patients with prior
PTMC were female (75%) which was comparable to Iung et al6
(89%) and Pathan et al26 (75%). In our study patients with prior
PTMC have higher echocardiographic score (68.18% having >8
score compared to 50% in both Iung et al6 and Pathan et al26)
and different proportion of AF population (25% as compared to
11% in Iung et al6 and 61% in Pathan et al.26)
PTMC has a success rate of 80e95% in de novo mitral ste-
nosis.18 However for PTMC in mitral restenosis, success rate
varies between 50 and 90%.6e10,26,28. Our study showed overall
success rate of 77.14% and patients with prior PTMC having
84.1% and patients with prior surgical commissurotomy hav-
ing 65.4% success rate.
Mitral restenosis inpatientswith rheumatic valvulardisease
occurspredominantly by leaflet and subvalvar fusion invarious
studies commissural fusion was rarely seen in re-stenotic
mitral valves in many studies31 and all the splits produced in
commissures after PTMC were still present in re-stenotic
valves. Studies have suggested that effect of initial PTMC is
due to separation of fused commissures and that of secondPTMC is mainly due to stretch of leaflet and relief of subvalvar
stenosis.29e31 After a prior surgical commissurotomy, distorted
cardiac anatomy because of a prior ventriculotomy, amputated
left atrial appendage and surgical adhesions6e10 are a concern
in attempting PTMC because of fear of failure. In our study
however there was no procedural failure in this subgroup.
Studies have shown variable success rate in groups of pa-
tients with prior PTMC and prior surgical commissurotomy.
Previous studies by Nair et al10 showed similar immediate
results in prior BMV (57.1%) vs prior CMC (59%) group (p ¼ 1).
Chandrasekar et al32 found good immediate success rate of
85% in patients with prior surgical valvotomy. Ha et al9 also
showed 75% success rate in patients with prior surgical
commissurotomy. Although Jang et al8 found worse immedi-
ate and midterm outcome of PTMC after surgical valvotomy,
they compared them with patients of de novo mitral stenosis.
Moreover they found that when correcting for echocardio-
graphic score, patients with score lesser or equal to 8 had
similar good results like control group. Similarly, Gupta et al7
found equal success rate of PTMC in post surgical valvotomy
patients. Our study has also shownno significant difference in
immediate outcome of repeat PTMC in patients with prior
surgical valvotomy vs patients with prior PTMC despite higher
age, longer duration of disease, higher atrial fibrillation and
higher Wilkins score in the prior surgical valvotomy group.
Complications like mitral regurgitation > grade II were no
different from other studies. It was seen in 8.57% of all cases
with 6.8% in prior PTMC group and 11.5% in prior surgical
commissurotomy (p> 0.05) whichwas similar to Ha et al9 (10%
in prior surgical commissurotomy) and Pathan et al26 (5.6% in
prior PTMC group).5. Limitation
It is a single center study with moderate number of patients.
Larger number of patients may be required to detect rare
events and complication rate.6. Conclusion
PTMC for mitral restenosis in patients with prior surgical
valvotomy is as effective as in patients with prior PTMC
despite older age, higher NYHA class, higher Wilkins score
and atrial fibrillation and can be strongly considered in all
patients with restenosis irrespective of the type of past pro-
cedures done.Conflicts of interest
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